Simpler Grants.gov #NOT-RM-25-018

NIH SenNet Program Stage 2 Technology Development Funding Opportunity

This opportunity is a forthcoming funding announcement from the National Institutes of Health (NIH) for Stage 2 of the Cellular Senescence Network (SenNet) Program. - Government Buyer: - National Institutes of Health (NIH), including the NIH Common Fund, National Institute on Aging, National Cancer Institute, and other NIH Institutes and Centers - Purpose and Scope: - Funding for research projects to advance understanding of senescent cell heterogeneity in health and disease - Development of innovative tools and technologies for identifying, characterizing, and targeting senescent cells in vivo - Emphasis on technology development and computational tools relevant to senescent cell identification and targeting - Funding Details: - Forecasted total funding: $6,000,000 - Up to 15 expected awards - Utilizes the UG3/UH3 activity code - Eligibility: - Open to nonprofits, government entities, businesses, and educational institutions - Products/Services Requested: - No specific OEMs, vendors, products, or purchase quantities are mentioned - Unique Requirements: - Focus on innovative, in vivo technologies and computational approaches for senescent cell research - Projects should address cellular senescence in the context of health and disease

Description

The NIH Common Fund, National Institute on Aging, National Cancer Institute, and additional NIH Institutes and Centers intend to publish a Notice of Funding Opportunity for Stage 2 of the Cellular Senescence Network (SenNet) Program. The program aims to understand the biological consequences of senescent cell heterogeneity in health and disease and to develop innovative tools and technologies for identifying, characterizing, and targeting senescent cells in vivo. Applications are not currently being solicited; this notice allows potential applicants time to develop collaborations and responsive projects. The funding opportunity will utilize the UG3/UH3 activity code and encourages investigators with relevant expertise to apply.

View original listing